Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Decay-accelerating factor (DAF; CD55)]

N H Choi-Miura1

  • 1Department of Physiological Chemistry, School of Pharmaceutical Sciences, Showa University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 30, 1999
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel human plasma proteins, IHRP (acute phase protein) and PHBP (serine protease), which bind to glycosaminoglycans.

Current medicinal chemistry. Cardiovascular and hematological agents·2004
Same author

Population study and validation of paternity testing for Thoroughbred horses by 15 microsatellite loci.

The Journal of veterinary medical science·2002
Same author

Hepatic injury-specific conversion of mouse plasma hyaluronan binding protein to the active hetero-dimer form.

Biological & pharmaceutical bulletin·2001
Same author

Immunolocalization of apolipoproteins in aortic atherosclerosis in American youths and young adults: findings from the PDAY study.

Atherosclerosis·2001
Same author

Change in expression of GBP28/adiponectin in carbon tetrachloride-administrated mouse liver.

Biochemical and biophysical research communications·2001
Same author

Proteolytic activation and inactivation of the serine protease activity of plasma hyaluronan binding protein.

Biological & pharmaceutical bulletin·2001
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles